394 results on '"Henle G"'
Search Results
202. Epstein-Barr virus and infectious mononucleosis.
203. Failure of convalescent gamma globulin to protect against homologous serum hepatitis.
204. Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.
205. CROSS-REACTIONS AMONG GAMMA-GLOBULINS OF VARIOUS SPECIES IN INDIRECT IMMUNOFLUORESCENCE.
206. Respiration and glycolysis of human cells grown in tissue culture.
207. Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma.
208. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.
209. NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES.
210. Studies on the prevention of mumps. VI. Evaluation of dosage schedules for inactivated mumps vaccine.
211. Studies on host-virus interactions in the chick embryo-influenza virus system; development of infectivity, hemagglutination, and complement fixation activities during the first infectious cycle.
212. Studies on the prevention of mumps. VI. The relationship of neutralizing antibodies to the determination of susceptibility and to the evaluation of immunization procedures.
213. Involvement of C group chromosomes in five Burkitt lymphoma cell lines.
214. Attempts to influence the incomplete reproductive cycle of influenza virus in HeLa cells by antibodies.
215. Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy.
216. Immunofluorescence in cells derived from Burkitt's lymphoma.
217. EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions.
218. Studies on the prevention of mumps. III. The effect of subcutaneous injection of inactivated mumps virus vaccines.
219. Autogenous and virus-induced interferons from lines of lymphoblastoid cells.
220. Studies on persistent infections of tissue cultures. II. Nature of the resistance to vesicular stomatitis virus.
221. Studies on persistent infections of tissue cultures. IV. Evidence for the production of an interferon in MCN cells by myxoviruses.
222. Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
223. Experimental exposure of human subjects to viruses of influenza.
224. Interference in the detection of viral carrier states.
225. Cytolytic effects of mumps virus in tissue cultures of epithelial cells.
226. Apparent failure of chick-embryo-adapted hepatitis virus to immunize against natural virus.
227. Infectious mononucleosis and Reye's syndrome: a fatal case with studies for Epstein-Barr virus.
228. Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells.
229. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.
230. Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias.
231. THE DEMONSTRATION OF ONE-STEP GROWTH CURVES OF INFLUENZA VIRUSES THROUGH THE BLOCKING EFFECT OF IRRADIATED VIRUS ON FURTHER INFECTION.
232. Interference between polyoma and vesicular stomatitis viruses in tissue culture.
233. A non-transmissible cytopathogenic effect of influenza virus in tissue culture accompanied by formation of non-infectious hemagglutinins.
234. Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.
235. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
236. Effect of reovirus type 3 on cultured Burkitt's tumour cells.
237. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.
238. DIFFERENCES IN RESPONSE OF HAMSTER TUMOR CELLS INDUCED BY POLYOMA VIRUS TO INTERFERING VIRUS AND INTERFERON.
239. Studies on the toxicity of influenzal viruses; immunization of mice against the toxic activity of influenzal viruses; a new potency test for the assay of vaccines of influenzal virus.
240. [Herpesviruses with special reference to mononucleosis].
241. Isolation of mumps virus from human beings with induced apparent or inapparent infections.
242. Studies on the complement fixation antigens in mumps.
243. Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines.
244. Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells.
245. Experiments on vaccination of human beings against epidemic influenza.
246. STUDIES ON THE TOXICITY OF INFLUENZA VIRUSES : II. THE EFFECT OF INTRA-ABDOMINAL AND INTRAVENOUS INJECTION OF INFLUENZA VIRUSES.
247. Studies on the toxicity of influenza viruses.
248. Studies on the complement fixation antigens of influenza viruses types A and B.
249. Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery.
250. Antigen expression and colony formation of lymphoblastoid cell lines after superinfection with Epstein-Barr virus.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.